Clinical Trial Update: The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating sequential bevacizumab and atezolizumab in advanced hepatocellular carcinoma associated with MASLD; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: HCC - Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: RECRUITING